This document is an excerpt from the EUR-Lex website
Document 62014CN0273
Case C-273/14: Request for a preliminary ruling from the Conseil d’État (France) lodged on 5 April 2014 — Pierre Fabre Médicament v Ministre du Budget, des Comptes Publics et de la Réforme de l’État, Ministre des Affaires Sociales et de la Santé
Case C-273/14: Request for a preliminary ruling from the Conseil d’État (France) lodged on 5 April 2014 — Pierre Fabre Médicament v Ministre du Budget, des Comptes Publics et de la Réforme de l’État, Ministre des Affaires Sociales et de la Santé
Case C-273/14: Request for a preliminary ruling from the Conseil d’État (France) lodged on 5 April 2014 — Pierre Fabre Médicament v Ministre du Budget, des Comptes Publics et de la Réforme de l’État, Ministre des Affaires Sociales et de la Santé
IO C 282, 25.8.2014, p. 23–23
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
25.8.2014 |
EN |
Official Journal of the European Union |
C 282/23 |
Request for a preliminary ruling from the Conseil d’État (France) lodged on 5 April 2014 — Pierre Fabre Médicament v Ministre du Budget, des Comptes Publics et de la Réforme de l’État, Ministre des Affaires Sociales et de la Santé
(Case C-273/14)
2014/C 282/29
Language of the case: French
Referring court
Conseil d’État
Parties to the main proceedings
Applicant: Pierre Fabre Médicament
Defendants: Ministre du Budget, des Comptes Publics et de la Réforme de l’État, Ministre des Affaires Sociales et de la Santé
Question referred
Do points 3 and 5 of Article 6 of Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems (1) apply to decisions removing a proprietary product from the list of medicinal products administered to inpatients in health establishments that may be covered by compulsory health insurance schemes in addition to hospital treatments covered in the context of fixed payments for stays and care determined by diagnosis related group?